Literature DB >> 10574414

Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR).

M A Newaz1, N N Nawal.   

Abstract

The aim of this study was to determine the effects of gamma tocotrienol on lipid peroxidation and total antioxidant status of spontaneously hypertensive rats (SHR), comparing them with normal Wistar Kyoto (WKY) rats. SHR were divided into three groups and treated with different doses of gamma tocotrienol (gamma1, 15 mg/kg diet; gamma2, 30 mg/kg diet and gamma3, 150 mg/kg diet). Normal WKY and untreated SHR were used as normal (N) and hypertensive control (HC). Blood pressure were recorded every fortnightly for three months. At the end of the trial, animals were killed and measurement of plasma total antioxidant status, plasma superoxide dismutase (SOD) activity and lipid peroxide levels in plasma and blood vessels were carried out following well established methods. Study shows that lipid peroxides were significantly higher in hypertensive plasma and blood vessels compared to that of normal rats (Plasma- N: 0.06+/-0.01, HC: 0.13+/-0.008; p<0.001, B1. Vessels - N: 0.47+/-0.17, HC: 0.96+/-0.37; p<0.001). SOD activity was significantly lower in hypertensive than normal rats (N = 148.58+/-29.56 U/ml, HC = 110.08+/-14.36 U/ml; p = 0.014). After three months of antioxidant trial with gamma-tocotrienol, it was found that all the treated groups have reduced plasma lipid peroxides concentration but was only significant for group gamma1 (gamma1: 0.109+/-0.026, HC: 0.132+/-0.008; p = 0.034). On the other hand, lipid peroxides in blood vessels reduced significantly in all treated groups (gamma1; p<0.05, gamma2; p<0.001, gamma3; p<0.005). All the three treated groups showed improve total antioxidant status (p<0.001) significantly. SOD activity also showed significant improvement in all groups (gamma1: p<0.001, gamma2: p<0.05, gamma3: p<0.001). Correlation studies showed that, total antioxidant status (TAS) and SOD were significantly negatively correlated with blood pressure in normal rats (p = 0.007; p = 0.008) but not in SHR control. This correlation regained in all three groups SHR's after treatment with tocotrienol. Lipid peroxides in blood vessel and plasma showed a positive correlation with blood pressure in normal and SHR control. This correlation also remains in treated groups significantly except that in gamma3 where positive correlation with plasma lipid peroxide was not significant. In conclusion it was found that antioxidant supplement of gamma-tocotrienol may prevent development of increased blood pressure, reduce lipid peroxides in plasma and blood vessels and enhanced total antioxidant status including SOD activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574414     DOI: 10.3109/10641969909070850

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  14 in total

Review 1.  Utilization of Vitamin E Analogs to Protect Normal Tissues While Enhancing Antitumor Effects.

Authors:  Nukhet Aykin-Burns; Rupak Pathak; Marjan Boerma; Thomas Kim; Martin Hauer-Jensen
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

Review 2.  Tocotrienols: Vitamin E beyond tocopherols.

Authors:  Chandan K Sen; Savita Khanna; Sashwati Roy
Journal:  Life Sci       Date:  2006-02-03       Impact factor: 5.037

Review 3.  Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.

Authors:  Bharat B Aggarwal; Chitra Sundaram; Seema Prasad; Ramaswamy Kannappan
Journal:  Biochem Pharmacol       Date:  2010-08-07       Impact factor: 5.858

Review 4.  Tocotrienols: the emerging face of natural vitamin E.

Authors:  Chandan K Sen; Savita Khanna; Cameron Rink; Sashwati Roy
Journal:  Vitam Horm       Date:  2007       Impact factor: 3.421

5.  The antihypertensive effect of ethyl acetate extract from red raspberry fruit in hypertensive rats.

Authors:  Han Jia; Ji Wen Liu; Halmurat Ufur; Geng Sheng He; Hai Liqian; Peipei Chen
Journal:  Pharmacogn Mag       Date:  2011-01       Impact factor: 1.085

6.  Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration.

Authors:  Lili Deng; Ying Peng; Yu Wu; Meilin Yang; Yuedi Ding; Quancheng Chen; Qiang Fu
Journal:  Lipids Health Dis       Date:  2014-04-09       Impact factor: 3.876

Review 7.  Pharmacological potential of tocotrienols: a review.

Authors:  Haseeb Ahsan; Amjid Ahad; Jahangir Iqbal; Waseem A Siddiqui
Journal:  Nutr Metab (Lond)       Date:  2014-11-12       Impact factor: 4.169

8.  The Vitamin E Analog Gamma-Tocotrienol (GT3) and Statins Synergistically Up-Regulate Endothelial Thrombomodulin (TM).

Authors:  Rupak Pathak; Sanchita P Ghosh; Daohong Zhou; Martin Hauer-Jensen
Journal:  Int J Mol Sci       Date:  2016-11-18       Impact factor: 5.923

9.  Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats.

Authors:  Weng-Yew Wong; Hemant Poudyal; Leigh C Ward; Lindsay Brown
Journal:  Nutrients       Date:  2012-10-22       Impact factor: 5.717

10.  Effect of Tocotrienols enriched canola oil on glycemic control and oxidative status in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial.

Authors:  Mohammadreza Vafa; Neda Haghighat; Nazanin Moslehi; Shahriar Eghtesadi; Iraj Heydari
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.